|
Oracle Cosmetics (CEO Ro Young-woo) has officially launched the flagship product "Retinotightening Ampoule" from the derma cosmetic brand "Dr. Oracle" in Olive Young's online mall and offline stores.
Dr. Oracle is a cosmedical brand focused on ingredients and is affiliated with the Oracle Medical Group, which operates over 100 branches worldwide, including Oracle Dermatology.
To celebrate the launch of the Retinotightening Ampoule, Dr. Oracle will conduct a discount promotion starting from July and hold a first-come, first-served review event for all customers who purchase the product at Olive Young.
The "Retinotightening Ampoule" is a slow-aging ampoule containing a patented ingredient called "Dermatinol™," developed exclusively by Dr. Oracle, which further stabilizes the third-generation retinol "HPR (Hydroxypinacolone Retinoate)" known for its superior stability compared to pure retinol.
This ampoule, which won first place in the Essence/Ampoule/Serum category at the 2023 Hwahae Awards, is formulated with ingredients specifically targeted at improving wrinkles that occur from the mid-20s and onward. In clinical trials, it showed improvements of 11.2% in eye wrinkles, 7.9% in nasolabial folds, 11.5% in frown lines, 10.6% in neck wrinkles, and 8.4% in forehead wrinkles after just four weeks. It also demonstrated a 30.9% improvement in skin radiance, confirming its effectiveness in enhancing skin elasticity and glow.
An Oracle Cosmetics representative stated, "We have launched the product in a larger size exclusively at Olive Young in response to the high demand from consumers. We plan to introduce a diverse lineup of products at Olive Young to allow customers to experience a wider range of our offerings." They further added, "As the leading player of the third-generation retinol in the rapidly diversifying slow-aging product market, we aim to strengthen our position."
| 
